Netherlands-based drug-delivery specialist OctoPlus will perform formulation development and clinical manufacturing for an unnamed mid-sized European drug maker. The work encompasses three products, ...

ATLANTA, Jan. 31, 2023 /PRNewswire/ -- Mikart, LLC –a comprehensive contract development and manufacturing organization announced the completion of a new liquids and suspensions suite in Atlanta, ...

WuXi STA, a subsidiary of WuXi AppTec, reports that a new parenteral formulation manufacturing line has started operation at the drug product site in Wuxi city, China. It is the second line opened ...

WuXi STA launched a high potency, fully-automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new line has an annual capacity of 12 million units and meets ...

The two companies intend to leverage their complementary expertise and technology to bring a novel long acting injectable and drug product manufacturing platform to market. SACRAMENTO, Calif., Aug. 12 ...

Another addition to Amneal's growing complex injectables portfolio reflects leadership in advanced development and manufacturing of complex pharmaceuticals BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE ...

While many headline-grabbing biologics and advanced therapeutics like cell and gene therapies are approved as injectables, CDMOs Bora Pharmaceuticals and Corealis Pharma understand that oral solid ...

Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS). Not ...

LAWRENCEVILLE, N.J. & LENEXA, Kan.--(BUSINESS WIRE)--Adare Pharmaceuticals, Inc., a clinical-stage pharmaceutical company and leading global provider of advanced pharmaceutical technologies, ...

BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of risperidone ...